NASDAQ: CSBR - Champions Oncology, Inc.

Rentabilité sur six mois: -8.84%
Secteur: Healthcare

Calendrier des promotions Champions Oncology, Inc.


À propos de l'entreprise

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process.

Plus de détails
In addition, it offers Lumin Bioinformatics, a dynamic analytic and visualization software that empowers cancer biologists to harness the power of computational science in a convenient and sophisticated tool. The company markets its products through internet, word of mouth, and sales force to patients and physicians. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.

Выручка 0.0271
EBITDA 0.000876
Число акций ао 0.01354 млрд
P/E 1001.04
P/S 4.73
P/BV 57.25
EV/EBITDA 142.59
Цена ао 5.02
ISIN US15870P3073
Сайт https://www.championsoncology.com
Валюта usd
IPO date 2003-01-10
Sector Health Care
Industry Life Sciences Tools & Services
Валюта отчета usd
Changement de prix par jour: +0.6652% (4.51)
Changement de prix par semaine: -5.61% (4.81)
Changement de prix par mois: +8.51% (4.184)
Changement de prix sur 3 mois: -10.1% (5.05)
Changement de prix sur six mois: -8.84% (4.98)
Changement de prix par an: -26.77% (6.2)
Evolution du prix sur 3 ans: -56.76% (10.5)
Evolution du prix sur 5 ans: -20.77% (5.73)
Evolution des prix depuis le début de l'année: -17.6% (5.51)

Sous-estimation

Nom Signification Grade
P/S 1.27 9
P/BV 14.78 1
P/E 197.15 1
EV/EBITDA -48 0
Total: 3.25

Efficacité

Nom Signification Grade
ROA, % -15.55 0
ROE, % -115.08 0
Total: 0

Dividendes

Nom Signification Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Devoir

Nom Signification Grade
Debt/EBITDA -6.16 10
Total: 9.4

Impulsion de croissance

Nom Signification Grade
Rentabilité Revenue, % 56.25 7
Rentabilité Ebitda, % 1540.91 10
Rentabilité EPS, % 221.98 10
Total: 7.4

ETF Partager, % Rentabilité pour l'année, % Dividendes, %
iShares Micro-Cap ETF 0.00839 36.318555985322 1.54048



Superviseur Titre d'emploi Paiement Année de naissance
Dr. Ronnie Morris M.D. CEO & Director 600k 1966 (58 années)
Mr. David Barry Miller M.B.A. Chief Financial Officer 285k 1969 (55 années)
Mr. Brady Davis President N/A 1969 (55 années)
Dr. Maria Mancini Ph.D. Chief Operating Officer N/A
Mr. Arthur Hanson Vice President of Technology N/A
Ms. Rachel A. Bunting M.B.A., M.S., MBA, MS Vice President of Global Marketing N/A
Mr. David DeOrnellis BS, CMAR, CPIA, RLATG Executive Vice President of Global Laboratory Operations N/A
Dr. Michael Ritchie M.B.A., Ph.D. Chief Commercial Officer N/A
Dr. Karin Abarca Heidemann Ph.D. Executive Vice President of Global Scientific Operations N/A
Dr. Marianna Zipeto Ph.D. Executive Vice President of Commercial, Research Services & Partnering N/A

Adresse: United States, Hackensack. NJ, One University Plaza - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://www.championsoncology.com